Home › Stocks › ZYBT

ZYBT — ZHENGYE BIOTECHNOLOGY HLDG L

Reported value held$1.08M
Funds holding (latest)20
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)6
Institutional value$64.40K · 50.38K sh
New / Add / Cut / Exit3 / 1 / 1 / 6 · Updated 2026-11-21
Top-5 / Top-10 concentration100.0% / 100.0%
Institutional holdings change Reducing -41.0% (-3.78K sh)
Institutional value change Down -5.6%

Fundamentals (SEC EDGAR XBRL)

Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.

Revenue TTM Revenue YoY Net income TTM Net income YoY ROE (TTM) Gross margin Net margin P/E (TTM) P/E pct P/B P/B pct
— — — — — — — — — — —

Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 6 SEC-registered investment managers reported holding ZYBT (ZHENGYE BIOTECHNOLOGY HLDG L) in their latest 13F filings, with a combined reported value of $64.40K across 50.38K shares. That is -41.0% by share count (-3.78K shares) versus the previous quarter, while reported value moved -5.6%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 3 opened new positions, 1 added to existing stakes, 1 trimmed, 6 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of ZHENGYE BIOTECHNOLOGY HLDG L (ZYBT) include Pacer Advisors, Inc., Invesco Ltd, MILLENNIUM MANAGEMENT LLC, ranked by reported 13F value among the 20 institutional holders on this page.

ZYBT is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 6 50.38K $64.40K -41.0%
Q2 2026 9 129.34K $87.74K -13.8%
Q1 2026 8 121.04K $113.00K -27.2%
Q4 2025 10 230.30K $264.85K +59.5%
Q3 2025 12 315.25K $1.23M -39.2%
Q2 2025 9 553.13K $2.97M +11897.3%
Q1 2025 3 1.34K $7.19K —

Over the 7 quarters shown, institutional share counts increased 3671% in aggregate (Q1 2025 → Q3 2026); the largest single-quarter swing was Q2 2025 (+11897.3%).

Top Institutional Holders (Q3 2026) — 6 funds

FundSharesValuePortfolio WeightChange
JANE STREET GROUP, LLC 27.26K $32.71K 0.00% New
StoneX Group Inc. 17.66K $25.61K 0.00% New
UBS Group AG 4.20K $5.04K 0.00% Reduce
ROYAL BANK OF CANADA 1.23K $1.00K 0.00% Hold
Robinhood Markets, Inc. 27 $32 0.00% New
Caitong International Asset Management Co., Ltd 7 $8 0.00% Add

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 9 funds

FundSharesValuePortfolio WeightChange
XTX Topco Ltd 48.87K $33.09K 0.00% Add
GEODE CAPITAL MANAGEMENT, LLC 29.07K $19.68K 0.00% New
Geode Capital Management 29.07K $19.68K 0.00% Hold
WINTON GROUP Ltd 12.73K $8.62K 0.00% Reduce
UBS Group AG 7.99K $5.41K 0.00% Reduce
ROYAL BANK OF CANADA 1.23K $1.00K 0.00% Hold
Morgan Stanley 248 $168 0.00% Reduce
JPMorgan Chase & Co 134 $93 0.00% New
Caitong International Asset Management Co., Ltd 1 $1 0.00% Hold

Q1 2026 — 8 funds

FundSharesValuePortfolio WeightChange
XTX Topco Ltd 44.15K $41.27K 0.00% Reduce
WINTON GROUP Ltd 33.39K $31.21K 0.00% Reduce
Geode Capital Management 29.07K $27.17K 0.00% Hold
UBS Group AG 8.04K $7.51K 0.00% Reduce
Tower Research Capital LLC (TRC) 4.91K $4.59K 0.00% Add
ROYAL BANK OF CANADA 1.23K $1.00K 0.00% New
Morgan Stanley 261 $244 0.00% Reduce
Caitong International Asset Management Co., Ltd 1 $1 0.00% Hold

Q4 2025 — 10 funds

FundSharesValuePortfolio WeightChange
WINTON GROUP Ltd 63.30K $72.79K 0.00% Add
XTX Topco Ltd 59.29K $68.18K 0.00% Add
Invesco Ltd 34.69K $39.89K 0.00% Reduce
Citadel Advisors 30.58K $35.16K 0.00% Add
Geode Capital Management 29.07K $33.43K 0.00% Hold
UBS Group AG 9.12K $10.48K 0.00% Add
Tower Research Capital LLC (TRC) 2.21K $2.54K 0.00% Reduce
Morgan Stanley 1.61K $1.85K 0.00% Reduce
JPMorgan Chase & Co 457 $526 0.00% New
Caitong International Asset Management Co., Ltd 1 $1 0.00% Hold

Q3 2025 — 12 funds

FundSharesValuePortfolio WeightChange
Pacer Advisors, Inc. 141.90K $772.88K 0.00% Add
Invesco Ltd 36.45K $95.50K 0.00% Reduce
XTX Topco Ltd 34.59K $90.62K 0.01% New
Geode Capital Management 29.07K $76.16K 0.00% Hold
WINTON GROUP Ltd 21.55K $56.45K 0.00% New
MILLENNIUM MANAGEMENT LLC 14.60K $38.26K 0.00% New
Millennium Management 14.60K $38.26K 0.00% New
Citadel Advisors 11.69K $30.61K 0.00% New
Tower Research Capital LLC (TRC) 4.46K $11.69K 0.00% Add
UBS Group AG 4.33K $11.34K 0.00% Reduce
Morgan Stanley 2.01K $5.26K 0.00% Reduce
Caitong International Asset Management Co., Ltd 1 $3 0.00% New

Q2 2025 — 9 funds

FundSharesValuePortfolio WeightChange
JANE STREET GROUP, LLC 193.98K $1.16M 0.00% New
UBS Group AG 154.51K $922.44K 0.00% Add
Pacer Advisors, Inc. 132.62K $456.26K 0.00% New
Invesco Ltd 36.84K $219.93K 0.00% New
Geode Capital Management 29.07K $173.53K 0.00% New
Tower Research Capital LLC (TRC) 3.34K $19.92K 0.00% Add
Morgan Stanley 2.44K $14.54K 0.00% Add
BNP PARIBAS FINANCIAL MARKETS 262 $1.56K 0.00% New
Bank of America Corp 73 $436 0.00% New

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
JANE STREET GROUP, LLC 27.26K — — — — 193.98K —
StoneX Group Inc. 17.66K — — — — — —
UBS Group AG 4.20K 7.99K 8.04K 9.12K 4.33K 154.51K 1.29K
ROYAL BANK OF CANADA 1.23K 1.23K 1.23K — — — —
Robinhood Markets, Inc. 27 — — — — — —
Caitong International Asset Management Co., Ltd 7 1 1 1 1 — —
Pacer Advisors, Inc. — — — — 141.90K 132.62K —
Invesco Ltd — — — 34.69K 36.45K 36.84K —
Geode Capital Management — 29.07K 29.07K 29.07K 29.07K 29.07K —
XTX Topco Ltd — 48.87K 44.15K 59.29K 34.59K — —
WINTON GROUP Ltd — 12.73K 33.39K 63.30K 21.55K — —
MILLENNIUM MANAGEMENT LLC — — — — 14.60K — —
Citadel Advisors — — — 30.58K 11.69K — —
Tower Research Capital LLC (TRC) — — 4.91K 2.21K 4.46K 3.34K 1
GEODE CAPITAL MANAGEMENT, LLC — 29.07K — — — — —
Morgan Stanley — 248 261 1.61K 2.01K 2.44K 46
BNP PARIBAS FINANCIAL MARKETS — — — — — 262 —
JPMorgan Chase & Co — 134 — 457 — — —
Bank of America Corp — — — — — 73 —
Millennium Management — — — — 14.60K — —

Download holders (CSV)

FAQ

Which funds hold ZYBT?

As of 2026-Q3, 6 institutional funds reported holding ZYBT (ZHENGYE BIOTECHNOLOGY HLDG L) in SEC 13F filings, with a combined reported value of $64.40K.

How many shares of ZYBT do institutions own?

13F filers reported 50.38K shares of ZYBT, worth $64.40K in aggregate at the end of 2026-Q3.

Is institutional ownership of ZYBT rising or falling?

Share counts moved -41.0% versus the prior quarter — distribution.

Who are the top institutional holders of ZYBT?

The largest 13F holders are Pacer Advisors, Inc., Invesco Ltd, MILLENNIUM MANAGEMENT LLC, Millennium Management, Citadel Advisors; the top 25 are ranked at the top of this page.

Who are the major shareholders of ZHENGYE BIOTECHNOLOGY HLDG L?

The major shareholders of ZHENGYE BIOTECHNOLOGY HLDG L (ZYBT) by reported 13F value are Pacer Advisors, Inc., Invesco Ltd, MILLENNIUM MANAGEMENT LLC, Millennium Management, Citadel Advisors, among 20 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own ZYBT" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/ZYBT/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →